Clinical Trials Browser

Interventional × milademetan × Lymphoid × Clear all

NCT01877382 2025-03-27

A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas

Phase 1 Completed

107 enrolled 29 charts

Lymphoma